开发一种用于检测人血清（血浆）中针对新冠病毒病原体的IgG抗体的酶联免疫吸附测定法。
Development of an enzyme-linked immunosorbent assay for the detection of IgG-antibodies to the causative agent of COVID-19 in human serum (plasma).
作者信息
Mardanly S G, Avdonina A S, Mamedova S G
机构信息
The closed corporation «EKOlab».
The state educational institution of higher education «The state humanitarian technological university».
出版信息
Klin Lab Diagn. 2020 Dec 4;65(11):683-687. doi: 10.18821/0869-2084-2020-65-11-683-687.
A new original Russian test kit for the detection of IgG-antibodies to the causative agent of COVID-19 - coronavirus SARS-CoV-2 by the method of enzyme-linked immunosorbent assay (ELISA) on a solid-phase «ELISA-SARS-CoV-2-AT-G» has been developed. In comparative tests with similar test systems «Vitrotest® SARS-CoV-2 IgG» (Vitrotest, Ukraine) and «Anti-SARS-Cov-2 ELISA (IgG)» (EUROIMMUN AG, Germany) high diagnostic efficiency of the new test system was shown.
已研发出一种全新的俄罗斯原装检测试剂盒，用于通过固相“ELISA-SARS-CoV-2-AT-G”酶联免疫吸附测定法（ELISA）检测针对COVID-19病原体——冠状病毒SARS-CoV-2的IgG抗体。在与类似检测系统“Vitrotest® SARS-CoV-2 IgG”（乌克兰Vitrotest公司）和“Anti-SARS-Cov-2 ELISA (IgG)”（德国EUROIMMUN AG公司）的对比测试中，新检测系统展现出了较高的诊断效率。
Zotero 插件